Details of the Drug

General Information of Drug (ID: DMZID5A)

• Drug Name: EN3488

Indication

Disease Entry	ICD 11	Status	REF
Non-muscle invasive bladder cancer	2C94	Phase 3	[1]

• Cross-matching ID: TTD ID: D09KHE

References

• [1] ClinicalTrials.gov (NCT00406068) Mycobacterial Cell Wall-DNA Complex in Treatment of BCG-refractory Patients With Non-muscle Invasive Bladder Cancer. U.S. National Institutes of Health.